Mitotech S.A.
Records under this name other than the patents Mitotech S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 10 of 10 · Back to Mitotech S.A.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,658,624 | Pharmaceutical compositions for preventing and treating eye pathologies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,213,392 | Pharmaceutical composition for use in medical and veterinary ophthalmology Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,724,313 | Pharmaceutical composition for use in medical and veterinary ophthalmology Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,572,821 | Pharmaceutical compositions for preventing and treating eye pathologies Formerly held In force Term ended Oct 20, 2026 · From the USPTO record | In force | Term ended Oct 20, 2026 | From the USPTO record |
| US 9,328,130 | Method of treating organism by biologically active compounds specifically delivered into mitochondria, pharmaceutical composition required for the use of the method and a compound applicable for this purpose Term ended Ended no later than Jul 24, 2026 · From the USPTO record | Term ended | Ended no later than Jul 24, 2026 | From the USPTO record |
| US 9,744,180 | Pharmaceutical formulations containing mitochondrially targeted antioxidants Lapsed on the fee record Ended Aug 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 29, 2025 | From the USPTO record |
| US 8,518,915 | Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases Lapsed on the fee record Ended Aug 27, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 27, 2025 | From the USPTO record |
| US 9,439,916 | Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition Lapsed on the fee record Ended Sep 13, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 13, 2024 | From the USPTO record |
| US 9,408,859 | Pharmaceutical compositions useful for preventing and treating cancer Lapsed on the fee record Ended Aug 9, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 9, 2024 | From the USPTO record |
| US 8,557,733 | Composition for regenerating and stimulating growth of plants and for adapting plants to different stress factors Lapsed on the fee record Ended Oct 15, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 15, 2021 | From the USPTO record |